Myocardial ischemia–reperfusion injury (MIRI) remains a central challenge in coronary artery disease. Timely revascularization salvages ischemic myocardium yet simultaneously triggers cardiomyocyte death that offsets therapeutic benefit. Apoptosis, necroptosis, pyroptosis, and ferroptosis are all executed during ischem...
Yi-Long Wang, Jian-Yong Du, Er-Dan Dong et al.· Cells· 0 citations
Obesity is driven by maladaptive adipose expansion, yet the intracellular machinery linking motor protein‐associated intracellular regulation to adipogenic transcription remains incompletely understood. Here, we identify adipocyte‐derived kinesin family member 13B (KIF13B) as a regulator of obesity‐associated metabolic...
Metabolic remodeling, defined as changes in the energy substrate preferences and energy production efficiency of the myocardium, is one of the pathogenic characteristics of failing hearts, though its molecular mechanisms remain incompletely understood. Through untargeted metabolomics coupled with targeted mass spectrom...
Hong-Tu Cui, Lu Fang, Huan-Huan Cao et al.· Science China Life Sciences· 0 citations
It is demonstrated that arterial organoids can self-organize into perfusable vascular networks in vivo and improve blood perfusion in ischemic tissues.
Wei-Jing Kong, Zi-Hang Pan, Yi Hong et al.· Nature Communications· 0 citations
Fibroblast-derived myocilin is identified as a fibroblast-derived mediator that drives cardiomyocyte mitochondrial dysfunction and ROS production in HF and a fibroblast–cardiomyocyte signaling axis in which myocilin disrupts cardiomyocyte metabolic homeostasis is identified.